Dow Up0.09% Nasdaq Down0.02%

Teva Pharmaceutical Industries Limited (TEVA)

-NYSE
52.28 Up 0.06(0.11%) Aug 27, 4:01PM EDT
|After Hours : 52.40 Up 0.12 (0.23%) Aug 27, 5:01PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 20,314,000   20,317,000   18,312,000  
Cost of Revenue9,607,000  9,665,000  8,797,000  
Gross Profit 10,707,000   10,652,000   9,515,000  
Operating Expenses
Research Development1,427,000  1,356,000  1,095,000  
Selling General and Administrative5,319,000  5,117,000  4,410,000  
Non Recurring2,312,000  1,974,000  901,000  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 1,649,000   2,205,000   3,109,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes1,649,000  2,205,000  3,109,000  
Interest Expense399,000  386,000  153,000  
Income Before Tax1,250,000  1,819,000  2,956,000  
Income Tax Expense(43,000)(137,000)127,000  
Minority Interest16,000  53,000  (9,000)
Net Income From Continuing Ops1,269,000  1,963,000  2,759,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,269,000   1,963,000   2,759,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,269,000   1,963,000   2,759,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.